Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of Ibudilast for Methamphetamine Dependence (IBUD ph II)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by University of California, Los Angeles
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Keith Heinzerling, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT01860807
First received: May 20, 2013
Last updated: February 21, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)